X0306 4 2017-12-07 0 0001717452 Odonate Therapeutics, Inc. ODT 0001178579 TANG KEVIN C 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 1 1 1 0 Chief Executive Officer 0001191935 TANG CAPITAL PARTNERS LP 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 0 0 1 0 0001232621 TANG CAPITAL MANAGEMENT LLC 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 0 0 1 0 0001495904 Lemkey John G 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Common Stock 2017-12-07 4 P 0 1291666 24.00 A 12202338 I By LP The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. The shares reported as beneficially owned by TCP include a total of 154,285 shares of common stock that are held of record by Odonate Holdings, LLC ("Holdings"). Holdings has granted a proxy to TCP giving TCP the sole authority to vote such shares. John G. Lemkey is the Chief Financial Officer of Odonate Therapeutics, Inc., as well as Chief Operating Officer of TCM. Mr. Lemkey has a pecuniary interest in a portion of the shares beneficially held by TCP. Both Mr. Tang and Mr. Lemkey disclaim beneficial ownership of the shares held by TCP, except to the extent of their pecuniary interest therein. /s/ Kevin C. Tang 2017-12-08 /s/ Kevin C. Tang, Managing Member of Tang Capital Management, LLC, General Partner 2017-12-08 /s/ Kevin C. Tang, Managing Member 2017-12-08 /s/ John G. Lemkey 2017-12-08